Cerevel Therapeutics Holdings Inc (CERE)
41.99
-0.11
(-0.26%)
USD |
NASDAQ |
Apr 23, 12:50
Cerevel Therapeutics Holdings Total Liabilities (Quarterly): 569.55M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 569.55M |
| September 30, 2023 | 549.00M |
| June 30, 2023 | 543.85M |
| March 31, 2023 | 498.64M |
| December 31, 2022 | 496.58M |
| September 30, 2022 | 490.35M |
| June 30, 2022 | 143.84M |
| Date | Value |
|---|---|
| March 31, 2022 | 97.05M |
| December 31, 2021 | 110.19M |
| September 30, 2021 | 104.40M |
| June 30, 2021 | 97.12M |
| March 31, 2021 | 68.07M |
| December 31, 2020 | 60.75M |
| September 30, 2020 | 7.930M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
7.930M
Minimum
Sep 2020
569.55M
Maximum
Dec 2023
274.10M
Average
127.02M
Median
Total Liabilities (Quarterly) Benchmarks
| AbbVie Inc | 124.31B |
| Immunogen Inc (DELISTED) | 260.50M |
| Bristol-Myers Squibb Co | 65.67B |
| Science 37 Holdings Inc (DELISTED) | 23.98M |
| Madrigal Pharmaceuticals Inc | 235.21M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.243B |
| Shareholders Equity (Quarterly) | 673.74M |